Cargando…

Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE‐HF study

AIMS: The primary aim of the TRIAGE‐HF trial was to correlate cardiac implantable electronic device‐generated heart failure risk status (HFRS) with signs, symptoms, and patient behaviours classically associated with worsening heart failure (HF). METHODS AND RESULTS: TRIAGE‐HF enrolled 100 subjects w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virani, Sean A., Sharma, Vinod, McCann, Mary, Koehler, Jodi, Tsang, Bernice, Zieroth, Shelley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165932/ https://www.ncbi.nlm.nih.gov/pubmed/29934976 http://dx.doi.org/10.1002/ehf2.12309

Ejemplares similares

Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines
por: MacDonald, Blair J., et al.
Publicado: (2023)

Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds
por: Sharma, Vinod, et al.
Publicado: (2014)

Triage‐HF Plus: a novel device‐based remote monitoring pathway to identify worsening heart failure
por: Ahmed, Fozia Zahir, et al.
Publicado: (2019)

The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Inpatients With Heart Failure
por: Poon, Stephanie, et al.
Publicado: (2022)

Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
por: Huitema, Ashlay A., et al.
Publicado: (2020)

Hyperkalemia in heart failure
por: Sidhu, Kiran, et al.
Publicado: (2020)

Hyperkalaemia in Heart Failure
por: Ismail, Umar, et al.
Publicado: (2021)

Incremental Value of Implantable Cardiac Device Diagnostic Variables Over Clinical Parameters to Predict Mortality in Patients With Mild to Moderate Heart Failure
por: Manlucu, Jaimie, et al.
Publicado: (2019)

Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure
por: Small, Roy S, et al.
Publicado: (2014)

Non‐invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM‐HF and TIM‐HF2 trials
por: Tütüncü, Serdar, et al.
Publicado: (2020)

Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting
por: Cowie, Martin R., et al.
Publicado: (2013)

Is 24/7 remote patient management in heart failure necessary? Results of the telemedical emergency service used in the TIM‐HF and in the TIM‐HF2 trials
por: Winkler, Sebastian, et al.
Publicado: (2021)

Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
por: Vaduganathan, Muthiah, et al.
Publicado: (2023)

Optimizing Access to Heart Failure Care in Canada During the COVID-19 Pandemic
por: Virani, Sean A., et al.
Publicado: (2020)

Prediction of heart failure hospitalizations based on the direct measurement of intrathoracic impedance
por: Zile, Michael R., et al.
Publicado: (2020)

Use of a device-based remote management heart failure care pathway is associated with reduced hospitalization and improved patient outcomes: TriageHF Plus real-world evaluation
por: Ahmed, F Z, et al.
Publicado: (2022)

Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction
por: Babick, Andrea, et al.
Publicado: (2012)

Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM‐HF2 trial
por: Stegmann, Tina, et al.
Publicado: (2020)

A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
por: Raj, Pema, et al.
Publicado: (2021)

Geographic variations in the PARADIGM-HF heart failure trial
por: Kristensen, Søren Lund, et al.
Publicado: (2016)

Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
por: Wijkman, Magnus O., et al.
Publicado: (2022)

Early detection of atrial fibrillation in patients with heart failure reduces the risk of subsequent hospitalization: a subanalysis of the randomized TIM-HF2 trial
por: Stegmann, Tina, et al.
Publicado: (2022)

Validation of a Heart Failure Risk Score in a Cohort of Cardiac Resynchronization Therapy Patients Under Remote Monitoring: Results from the TriageHF™ Algorithm
por: Cardoso, Isabel, et al.
Publicado: (2023)

The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review
por: Dyck, Garrison J. B., et al.
Publicado: (2019)

Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?
por: Correia, Luis Cláudio Lemos, et al.
Publicado: (2016)

The Heart Failure Optimization Study (HF-OPT): rationale and design
por: Sanchez, R., et al.
Publicado: (2023)

Decrease in the 30-day heart failure (HF) Rehospitalization Rate after the implementation of a HF managed protocol
por: Correa, AG, et al.
Publicado: (2009)

The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
por: Campbell, Ross T., et al.
Publicado: (2020)

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
por: Jhund, Pardeep S., et al.
Publicado: (2021)

The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies
por: Poon, Stephanie, et al.
Publicado: (2022)

Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial
por: Sydow, Hanna, et al.
Publicado: (2021)

Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HF
por: Rubattu, Speranza, et al.
Publicado: (2017)

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
por: Docherty, Kieran F, et al.
Publicado: (2020)

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study
por: Domingo, Mar, et al.
Publicado: (2021)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF)
por: Sin, Phyllis, et al.
Publicado: (2022)

The COVID-19 pandemic and heart failure: lessons from GUIDE-HF( )
por: Cowie, Martin R, et al.
Publicado: (2022)

Perils and Pitfalls With Associations in Heart Failure, Particularly in HF-pEF
por: Carson, Peter E.
Publicado: (2023)

Obstetric Telephone Triage
por: Engeltjes, Bernice, et al.
Publicado: (2020)

INTERVENE‐HF: feasibility study of individualized, risk stratification‐based, medication intervention in patients with heart failure with reduced ejection fraction
por: Zile, Michael R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aosnu9vht4q4u8vp098rlj2t0d